NEW FROM US: Clover Health: How the “King of SPACs” Lured Retail Investors Into a Broken Business Facing an Active, Undisclosed DOJ Investigation

cc @chamath

hindenburgresearch.com/clover/ $CLOV

(1/x)
Today, we reveal how Clover Health and its Wall Street celebrity promoter, Chamath Palihapitiya, misled investors about critical aspects of Clover’s business in the run-up to the company’s SPAC go-public transaction last month. $CLOV
Our investigation into $CLOV has spanned 4 months & more than a dozen interviews with former employees, competitors & experts, dozens of calls to doctor’s offices & a review of thousands of pages of government reports, insurance filings, regulatory filings & marketing materials.
$CLOV has not disclosed that its business and its software, called Clover Assistant, are under investigation by the DOJ, which is investigating at least 12 issues from kickbacks to marketing practices according to a Civil Investigative Demand (similar to a subpoena) we obtained
This Civil Investigative Demand and the corresponding investigation present a potential existential risk for a company that derives almost all of its revenue from Medicare, a government payor. Our research indicates that the investigation has merit. $CLOV
$CLOV claims that its best-in-class technology fuels its sales growth. We found that much of Clover's sales are driven by a major undisclosed related party deal and misleading marketing targeting the elderly.
These practices should not come as a surprise, given that in 2016, $CLOV was fined for misleading marketing practices by the Centers for Medicare & Medicaid Services (CMS).

The fine was issued after Clover's repeated failure to amend misleading statements about plan offerings.
$CLOV has a thinly-disclosed subsidiary called "Seek Insurance". Seek makes no mention of its relationship with Clover on its website yet misleadingly advertises to seniors that it offers "independent" and "unbiased" advice on selecting Medicare plans.
Seek's website claims “We don’t work for insurance companies. We work for you”, despite literally being owned by $CLOV, an insurance company.

Its activities are also under investigation by the DOJ.
In case there is any doubt that Seek is an extension of $CLOV's sales operation, Florida corporate records show that Seek’s Chief Sales Officer is Hiram Bermudez, who concurrently serves as Clover’s Head of Sales.

search.sunbiz.org/Inquiry/Corpor…
Multiple formers explained much of $CLOV's sales are fueled by a major undisclosed relationship between $CLOV & an outside brokerage controlled by $CLOV's Head of Sales, Hiram Bermudez.

One estimated Bermudez drove ~68% of total sales.
The former employees explained that $CLOV's Head of Sales took efforts to conceal the relationship by putting it in his wife's name “for compliance purposes”.

Insurance filings confirm this. The contract was put into his wife's name weeks after Clover's go-public announcement.
In a CNBC interview about $CLOV, Chamath proclaimed, unprompted, "they create transparency...they don't motivate doctors to upcode or do all kinds of things in order to get paid"

A former employee told us the DOJ is specifically asking about upcoding, or overbilling Medicare.
Multiple former employees explained $CLOV's software is primarily a tool to help the company increase coding reimbursement.

We provide detail on how the software captures & retains irrelevant diagnoses, which we believe deceives the healthcare system & poses a regulatory risk.
$CLOV claims its software “delights” physicians, but according to doctors and former employees we interviewed, they use it because Clover pays them extra to use it.

Physicians are paid $200 per visit to use the software, twice the normal reimbursement rate for a Medicare visit.
Doctors at key Clover providers described the software as "embarrassingly rudimentary", “a waste of my time” and as just another administrative hassle to deal with.
$CLOV CTO left 6 months before the first release of the supposed "disruptive" Clover Assistant software in July 2018 (likely a sign that development wasn’t going great.)

Clover’s executive team has been in turmoil, with 3 CFOs, 3 COOs, and 2 General Counsels in the last 4 years
Prior to founding Clover, CEO Vivek Garipalli owned 3 New Jersey hospitals through a company called CarePoint Health.

CarePoint was publicly lambasted for price-gouging; its Bayonne Medical hospital charged the highest prices for emergency room treatment in the entire country.
CarePoint’s predatory price-gouging was lucrative. But in 2020, New Jersey legislators accused Garipalli – now a public company CEO - of siphoning over $157m from his hospital network through a web of shell entities.

The transactions left the hospitals financially crippled.
Meanwhile, @chamath has described Garipalli as "an absolute proven moneymaker".

That could be because Chamath’s firm received over 20 million “founders shares” (worth ~$290 million at current prices) in exchange for $25,000 and for promoting the $CLOV SPAC.
Given that investors are paying over a quarter billion dollars for @chamath's due diligence, we think they deserve to know whether Chamath knew of these issues at $CLOV and concealed them, or whether he simply failed to notice them at all.

hindenburgresearch.com/clover/
Short sellers have exposed almost every major market fraud in the past several decades, yet there have been recent questions about whether they play an important role in a healthy, functioning market.

We hope our research today serves as a timely reminder that they do.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Hindenburg Research

Hindenburg Research Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @HindenburgRes

22 Dec 20
We are short $MVIS. In a market gone mad, this $1.2 billion market cap corporate husk with almost no revenue or intellectual property value is a standout.

It has risen 5,000% from lows this year on misguided retail euphoria over its LiDAR IP portfolio amid a broad EV bubble.
Retail investors have latched onto the company's portfolio of 250+ active patents, but an IP attorney we engaged found that only ~10 $MVIS issued patents even mention LiDAR.

Of those, many are oriented toward consumer/non-automotive use.
These patents haven't faced inter partes review (IPR) challenges yet, significantly reducing their value.

“No one buys patents these days for any real money unless the patents have been put through the test of at least an IPR,” our IP attorney told us.
Read 9 tweets
29 Sep 20
Tonight, CNBC released a bombshell article detailing multiple allegations of sexual abuse perpetrated by Trevor Milton, $NKLA founder, current largest shareholder (with ~24% ownership), recent Executive Chairman and former CEO.

(1/x)

cnbc.com/2020/09/29/two…
In light of the latest, let’s discuss the company’s backers, partners and bankers that have all recently tried to absolve themselves of liability by assuring the market and the public of their extensive due-diligence on $NKLA.
Following our report, which contained details of dozens of material false statements by $NKLA, the company failed to even attempt to answer 43 of 53 questions we raised.

Instead, it addressed roughly 10 questions, largely confirming our findings, and ignored the rest.
Read 13 tweets
10 Sep 20
New From Us: Nikola—How to Parlay An Ocean of Lies Into a Partnership With the Largest Auto OEM in America

hindenburgresearch.com/nikola $NKLA

(1/x)
Today, we reveal why we believe $NKLA is an intricate fraud built on dozens of lies over the course of its Founder and Executive Chairman Trevor Milton’s career.
We have gathered extensive evidence—including recorded phone calls, text messages, private emails and behind-the-scenes photographs—detailing dozens of false statements by $NKLA Founder Trevor Milton. We have never seen this level of deception at a public company.
Read 28 tweets
21 Aug 20
New from us: GrowGeneration—This Latest Euphoric Retail Stock Has The Brightest Management Red Flags We’ve Ever Seen—70%+ Downside

hindenburgresearch.com/growgeneration/

(1/x)
's management team is one of the most questionable we have ever seen at a public company. Top executives have extensive ties to alleged pump & dump schemes, organized crime and various acts of fraud. Image
President & Co-Founder Michael Salaman was alleged by the FTC to have engaged in scheme to sell credit card information without authorization.

He has an extensive career in penny stock failures alongside his father, Abraham Salaman, a twice-convicted fraudster w/ mob ties ImageImage
Read 13 tweets
23 Jul 20
New from us—Facedrive: A $1B+ ESG Stock Promotion with a Hollow Core Business, Flailing Business Pivots and Multi-Million Dollar Payments to an Opaque BVI Entity; 95% Downside

hindenburgresearch.com/facedrive/

(1/x)
recently went public with the core premise of being an “eco-friendly” ride hailing app allowing users to select electric vehicle or hybrid options.

EV excitement has fueled the stock to a ludicrous $1.4 billion market cap and an absurd 908x revenue multiple.
's already-limited Canada-based ridesharing business appears to have been dramatically impaired by COVID.

While the company claims 13,000 registered drivers on the platform, we estimate current active drivers at ~500-600 total, suggesting a 95% overstatement.
Read 13 tweets
10 Jul 20
We're short $WKHS because we think there's immediate 50% downside. The company has an astronomical valuation of ~$1.5B despite less than $100k in revenue last quarter.

We see the chance of winning a material USPS contract as virtually zero. A reality check is on its way.
Company insiders and key stakeholders seem to agree; they have been aggressively dumping shares over the past several weeks/months. We expect insiders to continue to unload.
$WKHS has a marginal 10% stake in Lordstown which needs ~$450m to even get off the ground, suggesting major dilution.

Retail investors & daytraders looking for the next $TSLA or $NKLA are in the wrong place, despite the recent widespread EV hype
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!